2015CO临床指南：视网膜静脉阻塞.doc

Clinical Guidelines Retinal Vein Occlusion (RVO) Guidelines July 2015 Contents Section Summary RVO Guidelines Expert Working Party Members Declarations of Interest Consultation process Search Strategy Review Date: September 2017 Preface EVIDENCE RECOMMENDATIONS Section 1: Terminology and Disease Definition Retinal vein occlusion (RVO) Central retinal vein occlusion (CRVO) Branch retinal vein occlusion (BRVO) Hemi-retinal vein occlusion (HRVO) Macular Oedema (MO): Retinal ischaemia and iris and retinal neovascularisation: Ischaemic versus non-ischaemic RVO: Section 2: Natural History of Retinal Vein Occlusions Central Retinal Vein Occlusion Branch Retinal Vein Occlusion Bilateral involvement Section 3: Epidemiology of Retinal Vein Occlusion Section 4: Aetiology and risk factors of Retinal Vein Occlusions Associations with retinal vein occlusions Section 5: The relation of RVO to systematic vein occlusions and the role of testing for venous occlusions risk factors Section 6: Cardiovascular morbidity and mortality Is RVO a predictor for the future development of stroke? Is RVO associated with increased mortality? Section 7: Distinct clinical entities of retinal vein occlusion Hemisphere vein occlusion RVO in younger patients (less than 50 years of age) Section 8: Medical investigations in retinal vein occlusions Summary of recommended medical investigations in the eye clinic: Section 9: Ophthalmological management of CRVO Macular oedema Anti-VEGF Therapies Translation of current clinical trials on anti-VEGF therapy in CRVO into clinical practice Ischaemic central retinal vein occlusion Management of ischaemic central retinal vein occlusion and anterior segment neovascularisation Management of posterior segment neovascularisation Pan-retinal Photocoagulation Technique Management of established neovascular glaucoma Recommendations for Further Follow-up Experimental treatments Section 10: Ophthalmological management of BRVO 2015/SCI/352  page 4 4 4 5 5 5 5 5 6 6 6 6